
Oncology nurse navigator Diane Stanaway discusses photosensitivity, new sunscreen innovations, and debunking common myths for patients and survivors.
A space created exclusively for advanced practice providers in oncology. Here, you’ll find a wealth of resources tailored to your needs, including insightful articles, event information, a comprehensive resource guide, and educational videos.
Our mission is to support your vital role in cancer care by providing the latest advances in therapy options, adverse effect management, and patient communication strategies. This is your hub for the tools and knowledge to enhance your expertise and empower your practice.

Oncology nurse navigator Diane Stanaway discusses photosensitivity, new sunscreen innovations, and debunking common myths for patients and survivors.

Maite San Miguel and a new survey highlight how specialized training and clinical autonomy are vital for optimizing multiple myeloma outcomes.

The FDA approved Tregzi, a precision-engineered cell therapy, to improve chronic GVHD-free survival in adults undergoing allogeneic transplant.

PROSPER data reveal that mogamulizumab provides rapid, sustained relief from skin symptoms and improves sleep for patients with MF and SS.

The FDA approved Azurity’s Aprepitant Injectable Emulsion, a polysorbate-80-free, ready-to-use IV option for preventing chemotherapy-induced nausea.